Investigations before, at and 6 weeks after presentation.
| Tests | 2 months before admission | At admission | 6 weeks after admission |
|---|---|---|---|
| Haemoglobin, g/dL | 11.2 | 10.5 | |
| Creatinine, mg/dL | 1.2 | 1.2 | |
| Urine ACR, μg/mg | 212 | ||
| HBA1c, % | 6.7 | 6.8 | |
| Retinopathy | Mild NPDR in both eyes | ||
| Na/K, mEq/L | 130/4.9 | ||
| Lipid profile LFT | WNL | ||
| ECG | Lateral wall ischaemia | ||
| 8 am serum cortisol, μg/dL | 6.5 | 4.5 | |
| ACTH, pg/mL | 4.2 | 4.0 | |
| FT4, ng/dL | 1.1 | 1.04 | |
| TSH, μIU/mL | 1.8 | 2.1 | |
| Testosterone, ng/dL | 423 | 220 | |
| Prolactin, μg/dL | 6 | 4.2 | |
| IGF-1, ng/mL | 158 | 152 | |
| Cortisol after short synacthen stimulation, μg/dL | 20.2 | 7.3 | |
| MRI brain | Partial empty sella with thinned out pituitary tissue anchored in the floor of the sella |
ACR = albumin creatinine ratio; ACTH = adrenocortical trophic hormone; ECG = electrocardiogram; FT4 = free thyroxin, HBA1c = glycated haemoglobin; IGF1 = insulin-like growth factor 1; K = potassium; LFT = liver function test; MRI = magnetic resonance imaging = Na = sodium; NPDR = nonproliferative retinopathy; TSH = thyroid stimulating hormone; WNL = within normal limit.